{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T07:40:15Z","timestamp":1792309215838,"version":"4.4.0"},"reference-count":38,"publisher":"SAGE Publications","issue":"4","license":[{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Urologia"],"published-print":{"date-parts":[[2026,11]]},"abstract":"<jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>To systematically compare thulium fiber laser enucleation of the prostate (ThuFLEP) with holmium laser enucleation of the prostate (HoLEP) in terms of efficacy, safety, and perioperative outcomes in men undergoing surgical treatment for benign prostatic hyperplasia (BPH).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods:<\/jats:title>\n                    <jats:p>This systematic review and meta-analysis was conducted according to the PRISMA 2020 guidelines and registered in PROSPERO (CRD420251057100). PubMed, Scopus, Web of Science, EMBASE, and Google Scholar were searched up to March 2025 for randomized controlled trials and comparative observational studies that evaluated ThuFLEP versus HoLEP. The primary outcomes were perioperative parameters (operative time, catheterization duration, and length of hospital stay) and functional outcomes (International Prostate Symptom Score (IPSS) and maximum urinary flow rate (Qmax)). Secondary outcomes included blood loss, transfusion rate, and postoperative complications graded using the Clavien\u2013Dindo classification.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Twelve studies comprising 1248 patients (624 ThuFLEP and 624 HoLEP) met the inclusion criteria. Both techniques yielded comparable functional improvements, with no meaningful differences in the postoperative IPSS, Qmax, or post-void residual volume. ThuFLEP showed perioperative advantages, including a shorter operative time (mean difference (MD) \u221212.4\u2009min; 95% CI \u221220.1 to \u22124.7), shorter catheterization duration (MD \u22120.58\u2009days; 95% CI \u22120.81 to \u22120.35), and shorter hospital stay (MD \u22120.73\u2009days; 95% CI \u22121.02\u2009to\u2009\u22120.44). Bleeding-related outcomes favored ThuFLEP, with lower estimated blood loss and fewer transfusions. Overall postoperative complication rates and high-grade complications (Clavien\u2013Dindo\u2009\u2a7e\u2009III) were similar between the groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>ThuFLEP provides functional outcomes equivalent to those of HoLEP while offering improved perioperative efficiency and favorable bleeding-related outcomes. Both procedures appear to be safe and effective for treating BPH. Further large multicenter randomized trials with long-term follow-up are needed to confirm durability and evaluate cost-effectiveness.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/03915603261440216","type":"journal-article","created":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T13:38:56Z","timestamp":1777469936000},"page":"560-572","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparative analysis of thulium fiber laser enucleation of the prostate (ThuFLEP) and holmium laser enucleation of the prostate (HoLEP) in the management of benign prostatic hyperplasia: A systematic review and meta-analysis"],"prefix":"10.1177","volume":"93","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5337-5226","authenticated-orcid":false,"given":"Basri","family":"\u00c7ak\u0131ro\u011flu","sequence":"first","affiliation":[{"name":"Department of Urology, Hisar Intercontinental Hospital, \u00dcsk\u00fcdar University Faculty of Medicine, Istanbul, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tu\u011frul Cem","family":"Gezmi\u015f","sequence":"additional","affiliation":[{"name":"Department of Urology, Hisar Intercontinental Hospital, \u00dcsk\u00fcdar University Faculty of Medicine, Istanbul, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,4,29]]},"reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"crossref","unstructured":"Speakman M Kirby R Doyle S et al. Burden of male lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH) - focus on the UK. BJU Int 2015; 115(4): 508\u2013519. https:\/\/doi.org\/10.1111\/bju.12745","DOI":"10.1111\/bju.12745"},{"key":"e_1_3_3_3_2","doi-asserted-by":"crossref","unstructured":"Cakiroglu B Acar \u0130C Uyan\u0131k BS. Outcomes of Rezum water vapor therapy for benign prostate obstruction with 1-year follow-up: largest real-world data from Turkey. Cent Eur J Urol 2025; 78(2): 144\u2013150. https:\/\/doi.org\/10.5173\/ceju.2024.0224","DOI":"10.5173\/ceju.2024.0224"},{"key":"e_1_3_3_4_2","doi-asserted-by":"crossref","unstructured":"Zaman Huri H Hui Xin C Sulaiman CZ. Drug-related problems in patients with benign prostatic hyperplasia: a cross sectional retrospective study. PLoS One 2014; 9(1): e86215. https:\/\/doi.org\/10.1371\/journal.pone.0086215","DOI":"10.1371\/journal.pone.0086215"},{"key":"e_1_3_3_5_2","doi-asserted-by":"crossref","unstructured":"Launer BM McVary KT Ricke WA et al. The rising worldwide impact of benign prostatic hyperplasia. BJU Int 2021; 127(6): 722\u2013728. https:\/\/doi.org\/10.1111\/bju.15286","DOI":"10.1111\/bju.15286"},{"key":"e_1_3_3_6_2","doi-asserted-by":"crossref","unstructured":"Jackson EM Khooblall P Lundy SD et al. A review of combined phosphodiesterase-5-Inhibitors and \u03b1-blockers versus phosphodiesterase-5-Inhibitors alone for lower urinary tract symptoms due to benign prostatic hyperplasia. Arab J Urol 2024; 22(1): 13\u201323. https:\/\/doi.org\/10.1080\/2090598X.2023.2220627","DOI":"10.1080\/2090598X.2023.2220627"},{"key":"e_1_3_3_7_2","doi-asserted-by":"crossref","unstructured":"Nickel JC Aaron L Barkin J et al. Canadian Urological Association guideline on male lower urinary tract symptoms\/benign prostatic hyperplasia (MLUTS\/BPH): 2018 update. Can Urol Assoc J 2018; 12(10): 303\u2013312. https:\/\/doi.org\/10.5489\/cuaj.5616","DOI":"10.5489\/cuaj.5616"},{"key":"e_1_3_3_8_2","doi-asserted-by":"crossref","unstructured":"Marchioni M Primiceri G Veccia A et al. Transurethral prostate surgery in prostate cancer patients: a population-based comparative analysis of complication and mortality rates. Asian J Urol 2024; 11(1): 48\u201354. https:\/\/doi.org\/10.1016\/j.ajur.2022.05.008","DOI":"10.1016\/j.ajur.2022.05.008"},{"key":"e_1_3_3_9_2","doi-asserted-by":"crossref","unstructured":"Wang B Zhang S Sun C et al. Comparison between a transurethral prostate split and transurethral prostate resection for benign prostatic hyperplasia treatment in a small prostate volume: a prospective controlled study. Ann Transl Med 2020; 8(16): 1016. https:\/\/doi.org\/10.21037\/atm-20-5462","DOI":"10.21037\/atm-20-5462"},{"key":"e_1_3_3_10_2","doi-asserted-by":"crossref","unstructured":"Porto JG Bhatia AM Bhat A et al. Evaluating transurethral resection of the prostate over twenty years: a systematic review and meta-analysis of randomized clinical trials. World J Urol 2024; 42(1): 639. https:\/\/doi.org\/10.1007\/s00345-024-05332-3","DOI":"10.1007\/s00345-024-05332-3"},{"key":"e_1_3_3_11_2","doi-asserted-by":"crossref","unstructured":"Enikeev D Okhunov Z Rapoport L et al. Novel thulium fiber laser for enucleation of prostate: a retrospective comparison with open simple prostatectomy. J Endourol 2019; 33(1): 16\u201321. https:\/\/doi.org\/10.1089\/end.2018.0791","DOI":"10.1089\/end.2018.0791"},{"key":"e_1_3_3_12_2","doi-asserted-by":"crossref","unstructured":"Benzouak T Addar A Prudencio-Brunello MA et al. Comparative analysis of holmium laser enucleation of the prostate (HoLEP) and robotic-assisted simple prostatectomy (RASP) in BPH Management: a systematic review and meta-analysis. J Urol 2024; 213(2): 150\u2013161. https:\/\/doi.org\/10.1097\/JU.0000000000004297","DOI":"10.1097\/JU.0000000000004297"},{"key":"e_1_3_3_13_2","doi-asserted-by":"crossref","unstructured":"Kampantais S Dimopoulos P Tasleem A et al. Assessing the learning curve of holmium laser enucleation of prostate (HoLEP). A systematic review. Urology 2018; 120: 9\u201322. https:\/\/doi.org\/10.1016\/j.urology.2018.06.012","DOI":"10.1016\/j.urology.2018.06.012"},{"key":"e_1_3_3_14_2","doi-asserted-by":"crossref","unstructured":"Dalton DC Shelton TM Rivera M. Laser technology advancements in the treatment of benign prostatic hypertrophy. Curr Urol Rep 2024; 25(4): 71\u201378. https:\/\/doi.org\/10.1007\/s11934-024-01197-6","DOI":"10.1007\/s11934-024-01197-6"},{"key":"e_1_3_3_15_2","doi-asserted-by":"crossref","unstructured":"Aybal HC Yilmaz M Barlas IS et al. HoLEP versus ThuFLEP in men with very large prostates (>\u2009175 ml). World J Urol 2025; 43(1): 109. https:\/\/doi.org\/10.1007\/s00345-025-05478-8","DOI":"10.1007\/s00345-025-05478-8"},{"key":"e_1_3_3_16_2","first-page":"6","article-title":"HoLEP: the new gold standard for surgical treatment of benign prostatic hyperplasia","volume":"28","author":"Shvero A","year":"2021","unstructured":"Shvero A, Calio B, Humphreys MR, et al. HoLEP: the new gold standard for surgical treatment of benign prostatic hyperplasia. Can J Urol 2021; 28(S2): 6\u201310.","journal-title":"Can J Urol"},{"key":"e_1_3_3_17_2","doi-asserted-by":"crossref","unstructured":"Taha T Savin Z Lifshitz K et al. Mini-HoLEP (MILEP) vs HoLEP: a propensity score-matched analysis. World J Urol 2023; 41(10): 2801\u20132807. https:\/\/doi.org\/10.1007\/s00345-023-04562-1","DOI":"10.1007\/s00345-023-04562-1"},{"key":"e_1_3_3_18_2","doi-asserted-by":"crossref","unstructured":"Kosiba M Filzmayer M Welte MN et al. Thulium fiber laser vs. holmium laser enucleation of the prostate: results of a prospective randomized non-inferiority trial. World J Urol 2024; 42(1): 49. https:\/\/doi.org\/10.1007\/s00345-023-04748-7","DOI":"10.1007\/s00345-023-04748-7"},{"key":"e_1_3_3_19_2","doi-asserted-by":"crossref","unstructured":"Enikeev D Taratkin M Babaevskaya D et al. Randomized prospective trial of the severity of irritative symptoms after HoLEP vs ThuFLEP. World J Urol 2022; 40(8): 2047\u20132053. https:\/\/doi.org\/10.1007\/s00345-022-04046-8","DOI":"10.1007\/s00345-022-04046-8"},{"key":"e_1_3_3_20_2","doi-asserted-by":"crossref","unstructured":"Petov V Babaevskaya D Taratkin M et al. Thulium fiber laser enucleation of the prostate: prospective study of mid- and long-term outcomes in 1328 patients. J Endourol 2022; 36(9): 1231\u20131236. https:\/\/doi.org\/10.1089\/end.2022.0029","DOI":"10.1089\/end.2022.0029"},{"key":"e_1_3_3_21_2","doi-asserted-by":"crossref","unstructured":"Perri D Besana U Mazzoleni F et al. Ejaculation-sparing enucleation of the prostate with thulium: yag laser (ES-ThuLEP) versus thulium fiber laser (ES-ThuFLEP): outcomes on sexual function. World J Urol 2025; 43(1): 92. https:\/\/doi.org\/10.1007\/s00345-025-05483-x","DOI":"10.1007\/s00345-025-05483-x"},{"key":"e_1_3_3_22_2","doi-asserted-by":"crossref","unstructured":"Elshal AM El-Nahas AR Ghazy M et al. Low-power vs high-power holmium laser enucleation of the prostate: critical assessment through randomized trial. Urology 2018; 121: 58\u201365. https:\/\/doi.org\/10.1016\/j.urology.2018.07.010","DOI":"10.1016\/j.urology.2018.07.010"},{"key":"e_1_3_3_23_2","doi-asserted-by":"crossref","unstructured":"Tuccio A Sessa F Campi R et al. En-bloc endoscopic enucleation of the prostate: a systematic review of the literature. Minerva Urol Nefrol 2020; 72(3): 292\u2013312. https:\/\/doi.org\/10.23736\/S0393-2249.20.03706-6","DOI":"10.23736\/S0393-2249.20.03706-6"},{"key":"e_1_3_3_24_2","doi-asserted-by":"crossref","unstructured":"Chen CH Chung CH Chu HC et al. Surgical outcome of anatomical endoscopic enucleation of the prostate: a systemic review and meta-analysis. Andrologia 2020; 52(8): e13612. https:\/\/doi.org\/10.1111\/and.13612","DOI":"10.1111\/and.13612"},{"key":"e_1_3_3_25_2","doi-asserted-by":"crossref","unstructured":"Gilling PJ Barber N Bidair M et al. Aquablation vs TURP in BPH: one-year outcomes from an RCT. Eur Urol 2019; 75(3): 581\u2013589. https:\/\/doi.org\/10.1016\/j.eururo.2018.09.036","DOI":"10.1016\/j.eururo.2018.09.036"},{"issue":"3","key":"e_1_3_3_26_2","first-page":"8802","article-title":"Durability of the prostatic urethral lift: 5-year results of the L.I.F.T. study","volume":"24","author":"Roehrborn CG","year":"2017","unstructured":"Roehrborn CG, Gange SN, Shore ND, et al. Durability of the prostatic urethral lift: 5-year results of the L.I.F.T. study. Can J Urol 2017; 24(3): 8802\u20138813.","journal-title":"Can J Urol"},{"key":"e_1_3_3_27_2","doi-asserted-by":"crossref","unstructured":"McVary KT Rogers T Roehrborn CG. Rez\u016bm water vapor thermal therapy for lower urinary tract symptoms associated with benign prostatic hyperplasia: 4-year results from randomized controlled study. Urology 2019; 126: 171\u2013179. https:\/\/doi.org\/10.1016\/j.urology.2018.12.041","DOI":"10.1016\/j.urology.2018.12.041"},{"key":"e_1_3_3_28_2","doi-asserted-by":"crossref","unstructured":"Nguyen DD Li T Ferreira R et al. Ablative minimally invasive surgical therapies for benign prostatic hyperplasia: a review of Aquablation Rezum and transperineal laser prostate ablation. Prostate Cancer Prostatic Dis 2024; 27(1): 22\u201328. https:\/\/doi.org\/10.1038\/s41391-023-00669-z","DOI":"10.1038\/s41391-023-00669-z"},{"key":"e_1_3_3_29_2","doi-asserted-by":"crossref","unstructured":"Jones P Alzweri L Rai BP et al. Holmium laser enucleation versus simple prostatectomy for treating large prostates: results of a systematic review and meta-analysis. Arab J Urol 2016; 14(1): 50\u201358. https:\/\/doi.org\/10.1016\/j.aju.2015.10.001","DOI":"10.1016\/j.aju.2015.10.001"},{"key":"e_1_3_3_30_2","doi-asserted-by":"crossref","unstructured":"Sandhu JS Bixler BR Dahm P et al. Management of lower urinary tract symptoms attributed to benign prostatic hyperplasia (BPH): AUA guideline amendment 2023. J Urol 2024; 211(1): 11\u201319. https:\/\/doi.org\/10.1097\/JU.0000000000003698","DOI":"10.1097\/JU.0000000000003698"},{"key":"e_1_3_3_31_2","doi-asserted-by":"crossref","unstructured":"Cornu JN Zantek P Burtt G et al. Minimally invasive treatments for benign prostatic obstruction: a systematic review and network meta-analysis. Eur Urol 2023; 83(6): 534\u2013547. https:\/\/doi.org\/10.1016\/j.eururo.2023.02.028","DOI":"10.1016\/j.eururo.2023.02.028"},{"key":"e_1_3_3_32_2","doi-asserted-by":"crossref","unstructured":"Castellani D Di Rosa M G\u00f3mez Sancha F et al. MoLEP vs ThuFLEP in a real-world setting. World J Urol 2023; 41(11): 2915\u20132923. https:\/\/doi.org\/10.1007\/s00345-023-04524-7","DOI":"10.1007\/s00345-023-04524-7"},{"key":"e_1_3_3_33_2","doi-asserted-by":"crossref","unstructured":"Calogero AE Burgio G Condorelli RA et al. Epidemiology and risk factors of LUTS\/BPH and erectile dysfunction. Aging Male 2019; 22(1): 12\u201319. https:\/\/doi.org\/10.1080\/13685538.2018.1434772","DOI":"10.1080\/13685538.2018.1434772"},{"key":"e_1_3_3_34_2","doi-asserted-by":"crossref","unstructured":"Carissimo H Coscarella M Al Barajraji M et al. Impact of mentoring in the perioperative safety of ThuFLEP technique. A two-center retrospective comparative study. Fr J Urol 2025; 35(6\u20137): 102906. https:\/\/doi.org\/10.1016\/j.fjurol.2025.102906","DOI":"10.1016\/j.fjurol.2025.102906"},{"key":"e_1_3_3_35_2","doi-asserted-by":"crossref","unstructured":"Bulai CA Multescu RD Geavlete PA et al. The impact of transurethral enucleation therapeutic approach in all-size benign prostatic obstruction pathology: from contemporary technological advances to evidence-based clinical progresses. Diagnostics 2025; 15(4): 416. https:\/\/doi.org\/10.3390\/diagnostics15040416","DOI":"10.3390\/diagnostics15040416"},{"key":"e_1_3_3_36_2","doi-asserted-by":"crossref","unstructured":"Tan C Wang C Huang J et al. Comparative outcomes of holmium laser enucleation of the prostate (HoLEP) versus robotic-assisted simple prostatectomy (RASP) for benign prostatic hyperplasia: a systematic review and meta-analysis. J Robot Surg 2025; 19(1): 478. https:\/\/doi.org\/10.1007\/s11701-025-02577-x","DOI":"10.1007\/s11701-025-02577-x"},{"key":"e_1_3_3_37_2","doi-asserted-by":"crossref","unstructured":"Almusafer M Narayan Y Nnorom I et al. Exploring pharmacological interventions in benign prostate hyperplasia: the role of cost-effectiveness analysis in daily practice and future directions. Expert Opin Pharmacother 2024; 25(7): 907\u2013914. https:\/\/doi.org\/10.1080\/14656566.2024.2362272","DOI":"10.1080\/14656566.2024.2362272"},{"key":"e_1_3_3_38_2","doi-asserted-by":"crossref","unstructured":"Gratzke C Bachmann A Descazeaud A et al. EAU guidelines on the assessment of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction. Eur Urol 2015; 67(6): 1099\u20131109. https:\/\/doi.org\/10.1016\/j.eururo.2014.12.038","DOI":"10.1016\/j.eururo.2014.12.038"},{"key":"e_1_3_3_39_2","doi-asserted-by":"crossref","unstructured":"Mamoulakis C Efthimiou I Kazoulis S et al. The modified Clavien classification system: a standardized platform for reporting complications in transurethral resection of the prostate. World J Urol 2011; 29(2): 205\u2013210. https:\/\/doi.org\/10.1007\/s00345-010-0566-y","DOI":"10.1007\/s00345-010-0566-y"}],"container-title":["Urologia Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/03915603261440216","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/03915603261440216","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/03915603261440216","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T07:07:13Z","timestamp":1792307233000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/03915603261440216"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,29]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["10.1177\/03915603261440216"],"URL":"https:\/\/doi.org\/10.1177\/03915603261440216","relation":{},"ISSN":["0391-5603","1724-6075"],"issn-type":[{"value":"0391-5603","type":"print"},{"value":"1724-6075","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,29]]}}}